WHO ICTRP trial
A comparative study of esketamine and dexmedetomidine on postoperative emotion…
ChiCTR2200064341 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200064341 |
|---|---|
| Public title | A comparative study of esketamine and dexmedetomidine on postoperative emotion in breast cancer patients |
| Scientific title | A comparative study of esketamine and dexmedetomidine on postoperative emotion in breast cancer patients |
| Primary sponsor | THE FIRST AFFILIATED HOSPITAL of GUANGXI MEDICAL UNIVERSITY |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Breast cancer |
| Interventions | esketamine group:0.5mg/kg esketamine i.v;Dexmedetomidine group:Pump 0.5µg/(kg*h)dexmedetomidine;Esketamine and dexmedetomidine group:0.5mg/kg esketamine i.v , pump 0.5µg/(kg*h)dexmedetomidine;control group:Nil |
| Registration date | Oct 3, 2022 |
| Target size | esketamine group:50;Dexmedetomidine group:50;Esketamine and dexmedetomidine… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: